Statistics for 10X Genomics (id:7297 TXG)

Valuation metrics

Market cap

1.71B

Enterprise value

1.49B

Trailing P/E (ttm)

-6.11

Forward P/E

-11.57

PEG ratio

-11.57

Price/Sales (ttm)

2.71

Price/Book (mrq)

2.36

Enterprise Value/Revenue

2.37

Enterprise Value/EBITDA

-11.08

Overview

Shares outstanding

107.00M

Float

104.96M

Shares short

7.61M

% Held by insiders

0.02%

% Held by institutions

0.92%

Average volume (10 days)

2.35M

Average volume (90 days)

Price summary

52-Week low

12.95

52-Week high

57.90

52-Week change

-225.53%

Beta

1.87

50-Day moving average

18.77

200-Day moving average

26.32

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-28.99%

Operating margin

-27.36%

Operational effectiveness

Return on assets

-11.37%

Return on equity

-24.87%

Income statement

Revenue (ttm)

5.26

Revenue per share (ttm)

5.26

Quarterly revenue growth (yoy)

Gross profit (ttm)

409.31M

EBITDA

-134,768,992.00

Net income to common (ttm)

-182,551,008.00

Diluted EPS (ttm)

-1.52

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

398.16M

Total cash per share (mrq)

3.29

Total debt (mrq)

85.88M

Total Debt/Equity (mrq)

11.88

Current ratio (mrq)

489.90%

Book value per share (mrq)

5.97

Cash flow

Cash flow statement

39.17M

Levered free cash flow (LFCF)

97.40M